Subscribe To
Philips' device for inferior vena cava filter removal scores fda approval
The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was give...
December 22, 2021, 1:19 pm
Philips' device for inferior vena cava filter removal scores fda approval
The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was give...
December 22, 2021, 1:19 pm
Philips' device for inferior vena cava filter removal scores fda approval
The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was give...
December 22, 2021, 1:19 pm
Kazia therapeutics appoints us-based cfo to assist global market expansion
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed Karen Krumeich as chief financial officer to focus on building and maintaining relationsh...
December 12, 2021, 6:48 pm
Kazia therapeutics appoints us-based cfo to assist global market expansion
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed Karen Krumeich as chief financial officer to focus on building and maintaining relationsh...
December 12, 2021, 6:48 pm
Kazia therapeutics appoints us-based cfo to assist global market expansion
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed Karen Krumeich as chief financial officer to focus on building and maintaining relationsh...
December 12, 2021, 6:48 pm
Archer materials develops sensing pathways to detect genetic information for biochip technology
Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has advanced its biochip technology a step further toward commercialisation, developing the first biochemica...
November 30, 2021, 10:31 pm
Archer materials develops sensing pathways to detect genetic information for biochip technology
Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has advanced its biochip technology a step further toward commercialisation, developing the first biochemica...
November 30, 2021, 10:31 pm
Archer materials develops sensing pathways to detect genetic information for biochip technology
Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has advanced its biochip technology a step further toward commercialisation, developing the first biochemica...
November 30, 2021, 10:31 pm
Novartis' iptacopan meets primary endpoint goal in rare kidney disease trial
Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C...
November 4, 2021, 1:45 pm
Novartis' iptacopan meets primary endpoint goal in rare kidney disease trial
Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C...
November 4, 2021, 1:45 pm
Novartis' iptacopan meets primary endpoint goal in rare kidney disease trial
Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C...
November 4, 2021, 1:45 pm
Pacira biosciences to acquire flexion therapeutics further expanding leadership position in non-opioid pain management
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain <...
October 11, 2021, 7:00 am
Pacira biosciences to acquire flexion therapeutics further expanding leadership position in non-opioid pain management
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain <...
October 11, 2021, 7:00 am
Pacira biosciences to acquire flexion therapeutics further expanding leadership position in non-opioid pain management
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain <...
October 11, 2021, 7:00 am
Why compass pathways stock dropped 12% in september
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....
October 5, 2021, 6:29 pm
Why compass pathways stock dropped 12% in september
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....
October 5, 2021, 6:29 pm
Why compass pathways stock dropped 12% in september
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....
October 5, 2021, 6:29 pm
Why compass pathways stock dropped 12% in september
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....
October 5, 2021, 6:29 pm
Why compass pathways stock dropped 12% in september
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....
October 5, 2021, 6:29 pm